Topics

CNS Tumors | Treatment | Clinical trials

Home > Publications > Topics > CNS Tumors > Treatment > Clinical trials

OVERALL MANAGEMENT

□ OVERVIEW

□ ANTIEPILEPTIC DRUGS

□ ARTIFICIAL INTELLIGENCE

□ CANCER BRAIN METS

□ COBIMETINIB

□ ENDOTHELIAL CELLS

□ GUT MICROBIOTA

□ METHODOLOGY

□ TRANSCRANIAL MAGN STIMUL

CHEMOTHERAPY

DIAGNOSIS / ASSESSMENT

□ DIFFERENTIATING RECURR

□ ENDOMICROSCOPY

IMMUNOTHERAPY

□ CAR-NK-CELLS

□ CAR-T-CELLS

□ CELL THERAPY

□ SOTIGALIMAB

□ TAA-T CELLS

□ VACCINES

INTEGRARIVE MEDICINE

□ GINGER

OFF-LABEL MEDICATIONS

□ ANTIFUNGALS

□ DEXMEDETOMIDINE

□ MEMANTINE

□ METFORMIN

□ SEDATION

RADIOTHERAPY

□ PROTON BEAM

□ RADIOSURGERY

□ RE-IRRADIATION

SIDE EFFECTS

□ COGNITIVE IMPAIRMENT

□ THROMBOEMBOLISM

SUPPORTIVE CARE

□ EXERCISE

□ PATIENT-REP OUTCOME

SURGERY

□ ANESTHESIA

□ BRAIN RELAXATION

□ HYPOTENSION

□ POSITIVE END-EXPIR PRESS

TARGETED THERAPY

□ ABM-1310

□ AFATINIB

□ DABRAFENIB

□ DEFACTINIB

□ DORDAVIPRONE (ONC201)

□ EVEROLIMUS

□ FADRACICLIB

□ IVOSIDENIB

□ LENVATINIB

□ MDM2 INHIBITORS

□ NIVOLUMAB

□ PEMIGATINIB

□ RAMUCIRUMAB

□ TRAMETINIB